Clayton S Lewis Selected Research

Clayton S Lewis Research Topics

8	Neoplasms (Cancer) 02/2024 - 01/2013
5	Adenocarcinoma 02/2024 - 03/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2013
2	Thrombosis (Thrombus) 03/2023 - 01/2019
2	Liver Diseases (Liver Disease) 03/2023 - 12/2018
1	End Stage Liver Disease 03/2023
1	Breast Neoplasms (Breast Cancer) 11/2022
1	Inflammation (Inflammations) 01/2018
1	Hypoxia (Hypoxemia) 12/2016
1	Carcinoma (Carcinomatosis) 03/2011
1	Hepatocellular Carcinoma (Hepatoma) 03/2011

6	Thromboplastin (Tissue Factor)IBA 02/2024 - 05/2016
4	Gemcitabine FDA Link 02/2024 - 01/2013
3	IntegrinsIBA 11/2022 - 05/2016
3	SphingosineIBA 01/2018 - 01/2013
2	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 09/2016 - 03/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	TubulinIBA 02/2024
1	LuciferasesIBA 02/2024
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2023
1	Protein Isoforms (Isoforms)IBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 09/2021
1	Albumin-Bound Paclitaxel FDA Link 01/2020
1	SaposinsIBA 01/2020
1	PhosphatidylserinesIBA 01/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	IsoenzymesIBA 01/2018
1	SphingolipidsIBA 01/2018
1	Carbonic Anhydrase IXIBA 12/2016
1	U-104IBA 12/2016
1	BromidesIBA 01/2013
1	2- N- (6'- (1'- pyridinium)hexanoyl)sphingosineIBA 01/2013
1	CeramidesIBA 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 03/2011
1	sphingosine kinaseIBA 03/2011
1	Drug CombinationsIBA 03/2011